Elromo 25 Tablets contain Eltrombopag 25mg, a thrombopoietin receptor agonist that helps stimulate platelet production. It is widely prescribed for patients with chronic immune thrombocytopenia (ITP), aplastic anemia, and low platelet counts due to chronic hepatitis C. Elromo is the trusted and affordable generic alternative to Promacta, offering effective platelet management and better quality of life for patients.
Key Uses
Treatment of chronic immune thrombocytopenia (ITP) in patients with insufficient response to corticosteroids or immunoglobulins
Management of aplastic anemia
Supportive treatment for low platelet counts caused by chronic hepatitis C therapy
Dosage & Administration
Usual starting dose: 25mg once daily, taken on an empty stomach (at least 1 hour before or 2 hours after meals)
Dose may be adjusted depending on platelet response and medical guidance
Always follow your doctor’s prescription for safe use
Benefits
Helps increase platelet production in blood
Reduces the need for platelet transfusions
Generic alternative to Promacta, ensuring cost savings
Improves patient outcomes in ITP, aplastic anemia, and hepatitis C–related thrombocytopenia
FAQs
Q1: What is Elromo 25 Tablet used for?
It is used to raise platelet counts in patients with ITP, aplastic anemia, or hepatitis C–related thrombocytopenia.
Q2: How should Elromo be taken?
Take it once daily on an empty stomach, as directed by your doctor.
Q3: Is Elromo the same as Promacta?
Yes, Elromo is the generic version of Promacta with the same active ingredient (Eltrombopag).
Q4: Can Elromo cure ITP?
No, it does not cure ITP but helps manage platelet levels and reduce bleeding risks.
Storage
Store below 30°C in a dry place
Keep away from direct sunlight and moisture
Keep out of children’s reach
Google Words Include:-
Elromo 25 price | Buy Elromo 25 online | Eltrombopag 25mg tablets | Promacta generic India | Elromo for low platelets | Thrombocytopenia treatment medicine | Eltrombopag tablets for ITP
✅ Conclusion:
Elromo 25 Tablets (Eltrombopag 25mg) are a reliable treatment option for patients with chronic ITP, aplastic anemia, and hepatitis C–related low platelet counts. As a cost-effective generic version of Promacta, it provides effective platelet management and better treatment accessibility.
